期刊文献+

四种血管特异生长因子mRNA与肝癌发生和门静脉瘤栓形成的关系 被引量:12

Correlation of four vascular specific growth factors mRNA with carcionogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma
下载PDF
导出
摘要 目的:探讨血管内皮生长因子(vascularendothelialgrowthfactor,VEGF)、促血管生成素2(angiopoietin,Ang2)、ephrinB2和内分泌腺源血管内皮生长因子(endocrinegland-derivedvascularendothelialgrowthfactor,EG-VEGF)在肝癌发生和门静脉瘤栓(PVTT)形I中的作用。方法:收集手术切除的无门静脉主干瘤栓的肝癌标本(A组)54例、伴门静脉主干瘤栓的肝癌标本(B组)9例和肝英化组织(C组)、正常肝组织(D组)各10例。用RT-PCR法检测标本中VEGF、Ang2、ephrinB2和EG-VEGF的表达。用免疫组织化学方法检测内皮细胞的标志分子CD34,并计数微血管密度(microvesseldensity,MVD),比较四组标本中各因子的表达和MVD水平。结果:A、B、C和D组的MVD分别为146·69±77·79、214·07±54·41、32·85±8·49和34·83±8·29,差异有统计学意义,F=19·77,P=0·000,且A组的MVD低于B组,P=0·006,高于C组,P=0·000。VEGF165、VEGF189、Ang2和EG-VEGFmRNA在四组标本中表达的差异有统计学意义,且VEGF165、Ang2和EG-VEGFmRNA在A、C两组和A、B两组内表达的差异有统计学意义(P值都<0·05或0·01)。肝癌中VEGF165、VEGF189、Ang2和EG-VEGFmRNA的表达与MVD正相关,rs分别为0·764、0·510、0·640和0·366,P值分别为0·000、0·000、0·000和0·003。结论:VEGF、Ang2和EG-VEGFmRNA与肝癌发生和MVD相关,并通过调控血管生成,促进肝癌门静脉瘤栓的形成。 OBJECTIVE.. To study the correlation between the expressions of vascular endothelial growth factor (VEGF), angiopoietin 2 (Ang2), ephrinB2 and endocrine gland-derived vascular endothelial growth factor (EG-VEGF) with carcionogenesis or portal vein tumor thrombus (PVTT) formation in human hepatocellular carcinoma (HCC). METHODS: Expressions of VEGF, Ang2, ephrinB2 and EG-VEGF were detected by RT-PCR in 54 cases of HCC without PVTT (group A), 9 cases of HCC with PVTT (group B), and 10 cirrhosis tissues (group C) 10 normal liver tissues (group D). The samples were also stained with CD34 by immunohistochemistry. Quantitation of microvessel density (MVD) and semi-quantitation of VEGF, Ang2, ephrinB2 and EG-VEGF expressions were analyzed to find the relations. RESULTS: The MVD(s) were 146. 69±77. 79, 214.07±54.41, 32.85±8. 49 and 34.83± 8. 29 in group A-D respectively with significant difference (F= 19. 77,P=0. 000). The MVD in group A was higher than that in group C (P=0. 006), but lower than that in group B (P= 0. 000). The expression levels of VEGF165, VEGF189, Ang2 and EG-VEGF mRNA were significantly different among the groups. The expression levels of VEGF165, Ang2 and EG-VEGF mRNA in group A were all higher than those in group C, but lower than those in group B (P〈0. 05 or 0. 01). The MVD was significantly correlated with VEGF165, VEGF189, Ang2 and EG-VEGF mRNA with Spearman's related coefficient being 0. 764, 0. 510, 0. 640 and 0. 366 respectively in HCC (P=0. 000, 0. 000, 0. 000 and 0. 003). CONCLUSIONS:VEGF, Ang2 and EG-VEGF mRNA may play sowe roles in angiogenesis and carcinogenesis of HCC. They can promote PVTT formation in HCC by modulating angiogenesis.
出处 《中华肿瘤防治杂志》 CAS 2006年第14期1085-1088,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 受体 生长因子 肝肿瘤/病理学 肝细胞 栓塞 肿瘤 receptors, growth factor live neoplasms/pathology carcinoma, hepatocellular embolus, tumor
  • 相关文献

参考文献17

  • 1Carmeliet P, Jain R K. Angiogenesis in cancer and other diseases[J]. Nature, 2000,407(6801) :249-257.
  • 2Kisliouk T, Levy N, Hurwitz A, et al. Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells[J]. J Clin Endocrinol Metab, 2003, 88(8):3700-3707.
  • 3Sugimachi K, Tanaka S, Taguchi K, et al. Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma[J]. J Clin Pathol, 2003,56(11):854-860.
  • 4Weidner N, Semple J P, Welch W R, et al. Tumor angiogenesis and metastasis correlation in invasive breast cancer[J]. N Engl J Med,1991,324(1) :1-8.
  • 5LeCouter J, Kowalski J, Foster J, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium[J].Nature, 2001,412 (6850) :877-884.
  • 6Goi T, Fujioka M, Satoh Y, et al. Angiogenesis and tumor proliferation/metastasis of human colorectal cancer cell line SW620 transfected with endocrine glands derived-vascular endothelial growth factor, as a new angiogenic factor[J].Cancer Res,2004,64 (6):1906-1910.
  • 7Zhang L, Yang N, Conejo-Garcia J R, et al. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma[J]. Clin Cancer Res, 2003, 9 ( 1 ) : 264-272.
  • 8Maekawa H, Oike Y, Kanda S, et al. Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol 3 kinase pathway and promotes angiogenesis in adult vasculature[J]. Arterioscler Thromb Vasc Biol, 2003,23 ( 11 ) : 2008-2014.
  • 9Zhang X Q, Takakura N, Oike Y, et al. Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin B2+ endothelial cells[J]. Blood, 2001,98 (4) : 1028-1037.
  • 10Park Y N, Kim Y B, Yang K M, et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis[J]. Arch Pathol Lab Med, 2000,124(7):1061-1065.

二级参考文献9

  • 1Kleihues P, Burger P C, Scheithauer B W. The new WHO clas sification of brain tumors [J]. Brain Pathol, 1993,3 ( 3 ): 255-268.
  • 2Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer [J]. Int J Cancer,1997,74(1):64-68.
  • 3Weidner N. Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and other solid tumors [J]. Breast Cancer Res Treat, 1995,36(2):169-180.
  • 4Valenzuela D M, Griffiths J A, Rojas J, et al. Angiopoietins 3 and 4: diverging gene counterparts in mice and humans [J].Proc Natl Acad Sci USA, 1999,96(5): 1904- 1909.
  • 5Ahmad S A, Liu W, Jung Y D, et al. The effects of angiopoietin 1 and-2 on tumor growth and angiogenesis in human colon cancer [J]. Cancer Res,2001,61(4):1255-1259.
  • 6Koga K, Todaka T, Morioka M, et al. Expression of angiopoieton-2 in human glioma cells and its role for angiogenesis [J].Cancer Res, 2001,61 ( 16 ): 6248- 6254.
  • 7Audero E, Cascone I, Zanon I, et al. Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis in vivo and in vitro studies [J]. Arterioscler Thromb Vasc Biol,2001,21(4) :536-541.
  • 8Q. Zheng,Z.-Y. Tang,Q. Xue,D.-R. Shi,H.-Y. Song,H.-B. Tang. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor[J] 2000,Journal of Cancer Research and Clinical Oncology(11):641~646
  • 9陈林莺.促血管生成素与肿瘤性血管生成的关系[J].国外医学(生理病理科学与临床分册),2002,22(4):368-370. 被引量:6

共引文献21

同被引文献38

引证文献12

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部